| +0.68 / +0.91%|
The 5 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 79.00, with a high estimate of 97.00 and a low estimate of 65.00. The median estimate represents a +4.82% increase from the last price of 75.37.
The current consensus among 6 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.